The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660
media
posted on 2022-10-31, 15:21 authored by Adis Rapid Journals on behalf of:, Robert Orenstein<p> </p>
<p><strong>Article full text</strong></p>
<p> <a href="https://link.springer.com/article/10.1007/s40121-022-00714-9" target="_blank">The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660 | SpringerLink</a> </p>
<p><br></p>
<p> The above video abstract represents the opinions of the <strong>author</strong>. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite). </p>
